Please login to the form below

Not currently logged in
Email:
Password:

Leqvio

This page shows the latest Leqvio news and features for those working in and with pharma, biotech and healthcare.

Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’

Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’

Also, Novartis’ Leqvio (inclisiran) – which has the added convenience of only being injected once every six months – has been approved in Europe but has only just started to be rolled out. ... Analysts at Evercore ISI have suggested Leqvio could

Latest news

More from news
Approximately 3 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Research Partnership

Research Partnership is now a member of Inizio Advisory, the consulting business unit of Inizio, a strategic partner for health...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...